SCHEMBL5771204

SCHEMBL5771204

CSc1nc(O)c2nc(-c3ccccc3)cc-2[nH]1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
KDM4E B2RXH2 4/20 0.48
HPGD P15428 2/20 0.48
LMNA P02545 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
POLB P06746 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
CDC7 O00311 3/20 0.43
HSD17B10 Q99714 1/20 0.42
PPARG P37231 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
RAB9A P51151 1/20 0.40
XDH P47989 1/20 0.39
PIM1 P11309 1/20 0.39
CSNK2A2 P19784 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5774884 0.82 CDC7 (0.47) ALDH1A1KDM4EHPGDPOLBCDC7
SCHEMBL5774357 0.81 ADORA3 (0.48) ALDH1A1KDM4EHPGDL3MBTL1POLB
SCHEMBL5771494 0.80 CDC7 (0.48) ALDH1A1KDM4EHPGDLMNAL3MBTL1
SCHEMBL5777145 0.78 XDH (0.51) ALDH1A1KDM4EHPGDLMNAPOLB
SCHEMBL5771811 0.78 CDC7 (0.46) ALDH1A1KDM4EHPGDLMNAL3MBTL1
SCHEMBL5771921 0.77 SMN1; SMN2 (0.55) ALDH1A1KDM4EHPGDL3MBTL1POLB
SCHEMBL5773858 0.77 ADORA1 (0.51) ALDH1A1KDM4EHPGDLMNAPOLB
SCHEMBL5774772 0.75 ADORA1 (0.53) ALDH1A1KDM4EHPGDPOLBSMN1; SMN2
SCHEMBL5772088 0.74 ESR1 (0.48) ALDH1A1KDM4EHPGDLMNAPOLB
SCHEMBL5769530 0.74 ADORA1 (0.54) ALDH1A1KDM4EHPGDPOLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed